Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease (SUNRISE-PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03720418
Recruitment Status : Terminated (As a result of termination of development of OXB-102-01, it is no longer possible for Sio to either commence or to continue any related clinical trials.)
First Posted : October 25, 2018
Last Update Posted : May 3, 2022
Information provided by (Responsible Party):
Sio Gene Therapies

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 12, 2022
Actual Study Completion Date : April 12, 2022